Cargando…
Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts”
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690333/ https://www.ncbi.nlm.nih.gov/pubmed/33244631 http://dx.doi.org/10.1007/s00228-020-03056-y |
| _version_ | 1783614049314930688 |
|---|---|
| author | Simon, Nicolas Alvarez, Jean Claude |
| author_facet | Simon, Nicolas Alvarez, Jean Claude |
| author_sort | Simon, Nicolas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7690333 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76903332020-11-27 Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts” Simon, Nicolas Alvarez, Jean Claude Eur J Clin Pharmacol Letter to the Editor Springer Berlin Heidelberg 2020-11-26 2021 /pmc/articles/PMC7690333/ /pubmed/33244631 http://dx.doi.org/10.1007/s00228-020-03056-y Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Simon, Nicolas Alvarez, Jean Claude Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts” |
| title | Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts” |
| title_full | Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts” |
| title_fullStr | Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts” |
| title_full_unstemmed | Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts” |
| title_short | Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts” |
| title_sort | reply to the letter to the editor “prediction of lopinavir/ritonavir effectiveness in covid-19 patients: a recall of basic pharmacology concepts” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690333/ https://www.ncbi.nlm.nih.gov/pubmed/33244631 http://dx.doi.org/10.1007/s00228-020-03056-y |
| work_keys_str_mv | AT simonnicolas replytothelettertotheeditorpredictionoflopinavirritonavireffectivenessincovid19patientsarecallofbasicpharmacologyconcepts AT alvarezjeanclaude replytothelettertotheeditorpredictionoflopinavirritonavireffectivenessincovid19patientsarecallofbasicpharmacologyconcepts |